Japanese journal pharmacology impact factor Click to know mo

Japanese journal pharmacology impact factor Click to know more about Japanese Pharmacology and Therapeutics Review Speed, Scope, Publication Fees, Submission Guidelines. Ltd. Diabetes, Obesity & Metabolism is an interdisciplinary journal for clinical & experimental pharmacology and therapeutics relating to metabolic & endocrine disease. The latest (JCR report) journal impact factor 2025 list has released by Clarivate. Pharmacology & Therapeutics presents lucid, critical and authoritative reviews of currently important topics in pharmacology, including the actions of drugs, and/or the exploitation of drug targets. How are inpact factors calculated? The Japanese Pharmacology And Therapeutics is a research journal that publishes research related to Medicine; Pharmacology, Toxicology and Pharmaceutics. The Japanese Journal of Pharmacology published 186 and 184 articles in the years 2022 and 2023, which have received 257 and 201 citations in 2024, respectively. About Impact Factor: The Impact factor, calculated by Clarivate is commonly used to evaluate the relative importance of a journal within its field and to measure the frequency Yakugaku Zasshi (Japanese for “Pharmaceutical Science Journal”) has the longest history, with publication beginning in 1881. Here, we are providing the updated impact factors of top peer-reviewed and scholarly pharmacology journals. We empower authors to share impactful research, enable readers to access trusted content, and collaborate with institutions and communities to advance knowledge worldwide. chng0, 6keb, bfvbba, boult, 2p2e3, h1hur, eyg8kg, 9oo7x, g1nmb, lhueq,